Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcriptional profiling of human kidney samples to discover gene signatures of progression and metastasis in renal cell cancer


ABSTRACT: In order to address the progression, metastasis, and clinical heterogeneity of renal cell cancer (RCC), transcriptional profiling with oligonucleotide microarrays (22,283 genes) was done on 49 RCC tumors, 20 non-RCC renal tumors, and 23 normal kidney samples. Samples were clustered based on gene expression profiles and specific gene sets for each renal tumor type were identified. Gene expression was correlated to disease progression and a metastasis gene signature was derived. Gene signatures were identified for each tumor type with 100% accuracy. Differentially expressed genes during early tumor formation and tumor progression to metastatic RCC were found. Subsets of these genes code for secreted proteins and membrane receptors and are both potential therapeutic or diagnostic targets. A gene pattern ("metastatic signature") derived from primary tumors was very accurate in classifying tumors with and without metastases at the time of surgery. A previously described "global" metastatic signature derived by another group from various non-RCC tumors was validated in RCC. Unlike previous studies, we describe highly accurate and externally validated gene signatures for RCC subtypes and other renal tumors. Interestingly, the gene expression of primary tumors provides us information about the metastatic status in the respective patients and has the potential, if prospectively validated, to enrich the armamentarium of diagnostic tests in RCC. We validated in RCC, for the first time, a previously described metastatic signature and further showed the feasibility of applying a gene signature across different microarray platforms. Transcriptional profiling allows a better appreciation of the molecular and clinical heterogeneity in RCC. We used the following tissue samples to obtain transcriptional profiling of kidney tumors using Affymetrix HGU-133A chips: 23 Normal, 32 clear cell RCC (cRCC), 11 papillary RCC (pRCC), 6 chromophobe RCC (chrRCC), 12 Oncocytoma (OC), and 8 transitional cell carcinoma (TCC). The supplementary file 'GSE15641_mas5_data.txt' contains MAS5 signal values for the Samples included in Series GSE15641. This dataset is part of the TransQST collection.

ORGANISM(S): Homo sapiens

SUBMITTER: Hasan Otu 

PROVIDER: E-GEOD-15641 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Gene signatures of progression and metastasis in renal cell cancer.

Jones Jon J   Otu Hasan H   Spentzos Dimitrios D   Kolia Shakirahmed S   Inan Mehmet M   Beecken Wolf D WD   Fellbaum Christian C   Gu Xuesong X   Joseph Marie M   Pantuck Allan J AJ   Jonas Dietger D   Libermann Towia A TA  

Clinical cancer research : an official journal of the American Association for Cancer Research 20050801 16


<h4>Purpose</h4>To address the progression, metastasis, and clinical heterogeneity of renal cell cancer (RCC).<h4>Experimental design</h4>Transcriptional profiling with oligonucleotide microarrays (22,283 genes) was done on 49 RCC tumors, 20 non-RCC renal tumors, and 23 normal kidney samples. Samples were clustered based on gene expression profiles and specific gene sets for each renal tumor type were identified. Gene expression was correlated to disease progression and a metastasis gene signatu  ...[more]

Similar Datasets

2009-04-28 | GSE15641 | GEO
2015-05-21 | E-GEOD-64052 | biostudies-arrayexpress
2020-08-07 | PXD011020 | Pride
2016-07-03 | E-GEOD-44548 | biostudies-arrayexpress
2012-08-13 | E-GEOD-39440 | biostudies-arrayexpress
2012-08-14 | GSE39440 | GEO
2023-12-29 | E-MTAB-12910 | biostudies-arrayexpress
2017-11-18 | GSE85699 | GEO
2011-02-01 | E-GEOD-24601 | biostudies-arrayexpress
2021-11-03 | PXD027065 | Pride